Table 4.
Group 1 | Group 2 | p | |
---|---|---|---|
(n = 59) | (n = 53) | ||
Survival > 24 hrs after surgery, n (%) | 55 (93.2) | 48 (90.6) | 0.73 |
Temporary inotropic agent, n (%) | 9 (16.4) | 9 (18.8) | 0.75 |
Complications | |||
New stroke, n (%) | 12 (21.8) | 8 (16.7) | 0.51 |
Heart failure, n (%) | 3 (5.5) | 2 (4.2) | 1.00 |
Respiratory failure, n (%) | 15 (27.3) | 14 (29.2) | 0.83 |
Acute kidney injury, n (%) | 8 (14.5) | 16 (33.3) | 0.02 |
Surgical wound infection, n (%) | 4 (7.3) | 2 (4.2) | 0.68 |
Pneumonia, n (%) | 22 (40) | 21 (43.8) | 0.70 |
GI bleeding, n (%) | 3 (5.5) | 6 (12.5) | 0.30 |
Arrhythmia, n (%) | 5 (9.1) | 10 (20.8) | 0.09 |
Survival to discharge, n (%) | 50 (84.7) | 41 (77.4) | 0.32 |
Duration of MV support (day) | 4 (2–9) | 4 (2–10.5) | 0.64 |
Length of ICU stay (day) | 9 (5–17.75) | 7 (5–18) | 0.67 |
Length of hospital stay (day) | 22 (15–40) | 24 (14–39.5) | 0.80 |
GI, gastrointestinal; ICU, intensive care unit; MV, mechanical ventilator.